Related Experiment Video
Updated: May 21, 2026

Deferred Growth Inhibition Assay to Quantify the Effect of Bacteria-derived Antimicrobials on Competition
Published on: September 3, 2016
MurD enzymes from different bacteria: evaluation of inhibitors
Hélène Barreteau1, Izidor Sosič, Samo Turk
1Univ Paris-Sud, Laboratoire des Enveloppes Bactériennes et Antibiotiques, UMR 8619, Orsay, F-91405, France.
Abstract:
D-Glutamic acid-adding enzyme (MurD ligase) catalyses the addition of D-glutamic acid to UDP-N-acetylmuramoyl-L-alanine, an essential cytoplasmic step in the pathway for bacterial cell-wall peptidoglycan synthesis. As such, it represents an important antibacterial drug-discovery target enzyme. Recently, several series of compounds have been synthesised and found to inhibit MurD from Escherichia coli, the best one having an IC(50) value of 8 μM. In the present work, we have tested 20 of these compounds against the MurD enzymes from Staphylococcus aureus, Streptococcus pneumoniae, Borrelia burgdorferi and Mycobacterium tuberculosis. Most of the E. coli MurD inhibitors appeared less efficient against the four other orthologues. This divergent result can be explained by the differences in amino acid sequences and topologies of the active sites of the MurD ligases studied.
Insights
Antibacterial drug discovery targeting bacterial D-glutamic acid-adding enzyme (MurD ligase) showed varied efficacy. Most inhibitors effective against E. coli MurD were less potent against orthologues from other bacteria due to active site differences.
Area of Science:
- Biochemistry
- Microbiology
- Drug Discovery
Background:
- D-Glutamic acid-adding enzyme (MurD ligase) is crucial for bacterial cell-wall peptidoglycan synthesis.
- MurD ligase is a significant target for developing novel antibacterial agents.
- Previous research identified inhibitors for Escherichia coli MurD with IC50 values as low as 8 μM.
Purpose of the Study:
- To evaluate the efficacy of known Escherichia coli MurD inhibitors against MurD enzymes from other bacterial species.
- To investigate the potential for broad-spectrum antibacterial activity of these inhibitors.
- To understand the structural basis for differential inhibition of MurD orthologues.
Main Methods:
- In vitro biochemical assays were used to test the inhibitory activity of 20 selected compounds.
- The compounds were tested against purified MurD ligase enzymes from Staphylococcus aureus, Streptococcus pneumoniae, Borrelia burgdorferi, and Mycobacterium tuberculosis.
- Enzyme inhibition was quantified using IC50 values.
Main Results:
- Most tested compounds showed reduced inhibitory efficiency against the MurD enzymes from Staphylococcus aureus, Streptococcus pneumoniae, Borrelia burgdorferi, and Mycobacterium tuberculosis compared to Escherichia coli.
- Significant variations in IC50 values were observed across different bacterial orthologues.
- The observed differences in inhibitor potency correlate with variations in the amino acid sequences and active site structures of the MurD ligases.
Conclusions:
- The efficacy of MurD inhibitors is species-specific, limiting their potential as broad-spectrum antibacterial agents.
- Structural differences in the active sites of MurD ligases from various bacteria contribute to differential drug responses.
- Further research is needed to develop MurD inhibitors with broader antibacterial coverage or to design targeted therapies for specific pathogens.
Related Concept Videos
Enzyme Inhibition
Gene Regulation in Microbial Communities: Quorum Sensing
Restriction Enzymes
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
Inhibitors of Bacterial DNA Synthesis
Antimicrobial Effectiveness

